News | January 12, 2026
AbbVie to acquire West Pharmaceutical’s Arizona device manufacturing facility
Supports production of AbbVie's current and next-generation immunology and neuroscience medicines
Supports production of AbbVie's current and next-generation immunology and neuroscience medicines
A key highlight will be Brenntag’s qualified amino acids portfolio
Increases speed to market for drug developers working on nucleic acid therapeutics
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency
TCS to help Apoteket drive its digital transformation across sales channels and internal processes
The deal brings three high-quality small-molecule drug substance sites into Siegfried’s portfolio
Siegfried plans to grow its exclusive synthesis business in the US by optimizing controlled substance capacity at the Wilmington and nearby Pennsville sites
Company to launch product after the expiry of semaglutide patent in India
Approval marks Venus Remedies’ first anti-infective marketing authorization in Indonesia and enables the country’s first generic entry for this critical antibiotic combination
India’s pharmaceutical sector stands at a pivotal inflection point
Subscribe To Our Newsletter & Stay Updated
